Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H20N2O5 |
Molecular Weight | 392.4046 |
Optical Activity | ( + ) |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC5=CC=C(O)C=C15
InChI
InChIKey=FJHBVJOVLFPMQE-QFIPXVFZSA-N
InChI=1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1
Molecular Formula | C22H20N2O5 |
Molecular Weight | 392.4046 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:42:23 UTC 2023
by
admin
on
Fri Dec 15 15:42:23 UTC 2023
|
Record UNII |
0H43101T0J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
840021
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
||
|
FDA ORPHAN DRUG |
513715
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
86639-52-3
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
PRIMARY | |||
|
104842
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
PRIMARY | |||
|
0H43101T0J
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
PRIMARY | |||
|
SUB188424
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
PRIMARY | |||
|
C61618
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
PRIMARY | |||
|
1347631
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
PRIMARY | |||
|
DB05482
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
PRIMARY | |||
|
100000174485
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
PRIMARY | |||
|
8988
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
PRIMARY | |||
|
SN-38
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
PRIMARY | |||
|
DTXSID4040399
Created by
admin on Fri Dec 15 15:42:24 UTC 2023 , Edited by admin on Fri Dec 15 15:42:24 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
BINDER->LIGAND |
The plasma protein to whichSN-38 predominantly binds is albumin.
BINDING
|
||
|
RACEMATE -> ENANTIOMER |
|
||
|
CONJUGATE -> TOXIN |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PARENT -> METABOLITE ACTIVE | |||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
INTRAVENOUS ADMINISTRATION |
|
||